Owners, management and financials
CVR: 39865769
Secondary names: Circle Biomedical Contraception ApS
Previous names: Circle Biomedical Contraception IVS, Cirqle Biomedical Contraception IVS
DKK -2,426,548
Gross profit
Net result: DKK -6,409,656
Cirqle Biomedical Holding ApS (66,66-89,99%), RH CAPITAL FUND II, LP (5-9,99%)
CVR · view owners
Frederik Petursson Madsen, Thomas Crouzier
Board: Jesper Boysen (chair) and 2 members
CVR · view management
Active
Founded 11 September 2018
CVR · view overview
2 employees
CVR · 2026
Owner registered: RH CAPITAL FUND II, LP
CVR · 21/09/2022
View the full event history
Cirqle Biomedical Contraception ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cirqle Biomedical Contraception IVS and Circle Biomedical Contraception IVS. The management consists of Frederik Petursson Madsen and Thomas Crouzier. The board consists of Jesper Boysen (chair), Frederik Petursson Madsen and Thomas Crouzier. The company is owned by Cirqle Biomedical Holding ApS and RH CAPITAL FUND II, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK -2,426,548 and a net result of DKK -6,409,656 compared with DKK 43,425,442 the year before. Equity in the 2025 report amounted to DKK 29,520,931.
Selskabets formål er at undersøge, udvikle og kommercialisere ny teknologi omkring præventionsmidler.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -2.4 mio. | -6.4 mio. | 31.5 mio. | 29.5 mio. | 4 | |
| 202401/01/2024 – 31/12/2024 | 60.6 mio. | 43.4 mio. | 39.5 mio. | 35.9 mio. | 7 | |
| 202301/01/2023 – 31/12/2023 | -12.8 mio. | -16 mio. | 45.9 mio. | 34.4 mio. | 9 | |
| 202201/01/2022 – 31/12/2022 | 62.1 mio. | 47.7 mio. | 70.2 mio. | 50.4 mio. | 5 | |
| 202101/01/2021 – 31/12/2021 | -5.8 mio. | -7.2 mio. | 3.6 mio. | -4.4 mio. | 5 | |
| 202001/01/2020 – 31/12/2020 | -4.1 mio. | -5.6 mio. | 10.8 mio. | 2.8 mio. | 5 |
Compared to 1.038 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Cirqle Biomedical Contraception ApS is 39865769.
Cirqle Biomedical Contraception ApS is owned by Cirqle Biomedical Holding ApS and RH CAPITAL FUND II, LP.
The management of Cirqle Biomedical Contraception ApS consists of Frederik Petursson Madsen and Thomas Crouzier.
The board of Cirqle Biomedical Contraception ApS consists of Jesper Boysen, Frederik Petursson Madsen and Thomas Crouzier, with Jesper Boysen as chair.
In 2025, Cirqle Biomedical Contraception ApS reported a gross profit of DKK -2,426,548.
Cirqle Biomedical Contraception ApS had 2 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Cirqle Biomedical Contraception ApS has published its annual report for 2025. Gross profit came to DKK -2,426,548, and the net result was DKK -6,409,656.
Cirqle Biomedical Contraception ApS has published its annual report for 2024. Gross profit came to DKK 60,578,876, and the net result was DKK 43,425,442.
Cirqle Biomedical Contraception ApS has published its annual report for 2023. Gross profit came to DKK -12,848,480, and the net result was DKK -15,984,818.
Cirqle Biomedical Contraception ApS has published its annual report for 2022. Gross profit came to DKK 62,142,237, and the net result was DKK 47,682,044.
As of September 21, 2022, is registered as an owner of Cirqle Biomedical Contraception ApS with an ownership share of 5%.
Cirqle Biomedical Contraception ApS has published its annual report for 2021. Gross profit came to DKK -5,768,965, and the net result was DKK -7,208,194.
Cirqle Biomedical Contraception ApS has published its annual report for 2020. Gross profit came to DKK -4,132,723, and the net result was DKK -5,557,693.
As of October 23, 2020, LPOG ApS STATSAUTORISEREDE REVISORER has been appointed auditor of Cirqle Biomedical Contraception ApS.
As of September 17, 2020, Frederik Petursson Madsen has joined the board of directors of Cirqle Biomedical Contraception ApS.
As of September 17, 2020, Jesper Boysen has joined the board of directors of Cirqle Biomedical Contraception ApS.
As of September 17, 2020, Thomas Crouzier has joined the board of directors of Cirqle Biomedical Contraception ApS.
As of September 17, 2020, Frederik Petursson Madsen is registered as adm. dir. of Cirqle Biomedical Contraception ApS.
On September 17, 2020, the company changed its name from Cirqle Biomedical Contraception IVS to Cirqle Biomedical Contraception ApS.
As of September 16, 2020, Frederik Petursson Madsen has stepped down as director of Cirqle Biomedical Contraception ApS.
Cirqle Biomedical Contraception ApS has published its interim report for the period September 11, 2018 to December 31, 2019.
On April 25, 2019, the company changed its name from Circle Biomedical Contraception IVS to Cirqle Biomedical Contraception IVS.
As of September 11, 2018, Frederik Petursson Madsen is registered as director of Cirqle Biomedical Contraception ApS.
As of September 11, 2018, Thomas Crouzier is registered as director of Cirqle Biomedical Contraception ApS.
As of September 11, 2018, Cirqle Biomedical Holding ApS is registered as an owner of Cirqle Biomedical Contraception ApS with an ownership share of 66%.
Cirqle Biomedical Contraception ApS was founded on September 11, 2018.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074
CVR 46543912
